Search results
Humanigen (HGEN) Plunges as COVID Study Fails to Meet Goal
Zacks via Yahoo Finance· 2 years agoThe NIAID's ACTIV-5/BET-B study evaluating Humanigen's (HGEN) lenzilumab plus remdesivir in...
Dr. Anthony Fauci, Face Of US COVID-19 Response, To Retire In December
Benzinga via Yahoo Finance· 2 years agoDr. Anthony S. Fauci has announced to step down from the Director of the National Institute of...
Moleculin Biotech's Potential Antiviral Compound Selected For NIAID-Funded Animal Studies
Benzinga via Yahoo Finance· 2 years agoMoleculin Biotech Inc (NASDAQ: MBRX) announced that its WP1096 molecule would be evaluated in animal...
Thermo Fisher (TMO) to Advance Clinical Research With New Pact
Zacks via Yahoo Finance· 7 months agoThermo Fisher Scientific, Inc. TMO recently collaborated with the National Minority Quality Forum...
Moderna (MRNA) Starts Early-Stage Nipah Virus Vaccine Study
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) doses the first participant in the phase I study of its investigational mRNA vaccine,...
10 Stocks to Buy Before the Next Pandemic
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we discuss the 10 stocks to buy before the next pandemic. If you wish to skip our comprehensive review of the biotech firms...
SIGA Updates on Progress Its Smallpox Drug Trials For Potential Use Against Monkeypox
Benzinga via Yahoo Finance· 2 years agoSIGA Technologies Inc (NASDAQ: SIGA) provided an update on the status of multiple clinical trials...
Ocugen (OCGN) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 weeks agoImage source: The Motley Fool. Ocugen (NASDAQ: OCGN) Q4 2023 Earnings Call Apr 02, 2024, 8:30 a.m. ET Contents: Prepared Remarks Questions and Answers...
Humanigen Stock: Why It Crashed and Where It’s Headed
TipRanks via Yahoo Finance· 2 years agoCovid-19 opened up plenty of opportunities for smaller pharma companies to make their mark, by...
Roche's (RHHBY) Xolair Gets Approval for Food Allergies
Zacks via Yahoo Finance· 2 months agoRoche RHHBY announced that the FDA has approved a label expansion of the asthma drug Xolair...
